Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Granulocyte Macrophage-Colony Stimulating Factor and Ipilimumab as Therapy in Melanoma (GIPI)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified March 2014 by Northern California Melanoma Center.
Recruitment status was:  Active, not recruiting
Sponsor:
Collaborator:
University of California, San Francisco
Information provided by (Responsible Party):
Lynn E. Spitler, MD, Northern California Melanoma Center
ClinicalTrials.gov Identifier:
NCT01363206
First received: May 27, 2011
Last updated: March 6, 2014
Last verified: March 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: May 2015
  Estimated Primary Completion Date: May 2014 (Final data collection date for primary outcome measure)